High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. (Q51011840)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 May 2017

Language	Label	Description	Also known as
English	High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.	scientific article published on 10 May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. (English)

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

12

object named as

T Tao

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

author name string

J Cai

1

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

C H Wu

2

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

Y Zhang

3

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

Y Y Wang

4

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

W D Xu

5

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

T C Lin

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

S X Li

7

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

L H Wang

8

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

J Zheng

9

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

Y Sun

10

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

W Liu

11

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

language of work or name

0 references

publication date

10 May 2017

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

International Journal of Obesity

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

41

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

9

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

1341-1347

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

https://scigraph.springernature.com/pub.10.1038/ijo.2017.116

0 references

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Insulin action in the normal and polycystic ovary

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Abnormal aminotransferase activity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Noninvasive evaluation of NAFLD.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Evidence and recommendations for imaging liver fat in children, based on systematic review

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

21 January 2018

Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatty liver index in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.116

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence and etiology of elevated aminotransferase levels in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/28487551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/28487551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/IJO.2017.116

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/28487551

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51011840&oldid=1588412727"